Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cerebrovascular Disorders × Fluorescein × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 5 Melanoma 3 Stomach Neoplasms 2 Neoplasms 2 Glioma 2 Glioblastoma 2 Breast Neoplasms 2 Thyroid Diseases 1 Skin Neoplasms 1 Sarcoma 1 Pancreatic Neoplasms 1 Paget Disease, Extramammary 1 Ovarian Neoplasms 1 Neuroma, Acoustic 1 Laryngeal Neoplasms 1 Irritable Bowel Syndrome 1 Gastrointestinal Stromal Tumors 1 Gastrointestinal Diseases 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1 Cerebrovascular Disorders 1 Carcinoma, Hepatocellular 1 Astrocytoma 1 Adenomatous Polyps 1 Adenolymphoma 1

Interventions

Vitamin E 1 Magnetoencephalography 1 Magnetic Resonance Imaging 1 Fluorescein 1 Enhanced Recovery After Surgery 1 Electrocardiography 1 Eating 1 Dexmedetomidine 1 Bupivacaine 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02478346 2017-02-14

Fluoescein

AdventHealth

Phase 4 Unknown

Brain Neoplasms, Cerebrovascular Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡